The borrelia hermsii factor H binding protein fhbA is not required for infectivity in mice or for resistance to human complement in vitro

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3324-3332

  Fine, Lindy M ^a,b   Miller, Daniel P ^a   Mallory, Katherine L ^a   Tegels, Brittney K ^a   Earnhart, Christopher G ^a   Marconi, Richard T ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND CENTER FOR ENVIRONMENTAL SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; FBHA PROTEIN; PLASMINOGEN; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BORRELIA HERMSII; BORRELIA INFECTION; CELL SURFACE; CONTROLLED STUDY; GENE DELETION; GENETIC MANIPULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; BORRELIA; CARRIER PROTEINS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; GENE DELETION; HUMANS; MICE; RELAPSING FEVER; VIRULENCE FACTORS;

EID: 84904767846     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01892-14     Document Type: Article

References (47)

1. Barbour AG, Hayes SF. 1986. Biology of Borrelia species. Microbiol. Rev. 50:381-400.
2. Cutler S, Talbert A. 2003. Tick-borne relapsing fever in Tanzania-a forgotten problem? ASM News 69:542-543.
3. Dupont HT, La Scola B, Williams R, Raoult D. 1997. A focus of tick-borne relapsing fever in southern Zaire. Clin. Infect. Dis. 25:139-144. http://dx.doi.org/10.1086/514496.
4. Jongen VH, van Roosmalen J, Tiems J, Van Holten J, Wetsteyn JC. 1997. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet. Gynecol. Scand. 76:834-838. http://dx.doi.org/10.3109 /00016349709024361.
5. Vial L, Diatta G, Tall A, Ba el H, Bouganali H, Durand P, Sokhna C, Rogier C, Renaud F, Trape JF. 2006. Incidence of tick-borne relapsing fever in West Africa: longitudinal study. Lancet 368:37-43. http://dx.doi .org/10.1016/S0140-6736(06)68968-X.
6. Dworkin M, Shoemaker P, Fritz C, Dowell M, Anderson DE, Jr. 2002. The epidemiology of tick-borne relapsing fever in the United States. Am. J. Trop. Med. Hyg. 66:753-758.
7. Dworkin MS, Anderson JDE, Schwan TG, Shoemaker PC, Banerjee SN, Kassen BO, Burgdorfer W. 1998. Tick-borne relapsing fever in the Northwestern United States and Southwestern Canada. Clin. Infect. Dis. 26:122-131. http://dx.doi.org/10.1086/516273.
8. Schwan TG, Policastro PF, Miller Z, Thompson RL, Damrow T, Keirans JE. 2003. Tick-borne relapsing fever caused by Borrelia hermsii in Montana. Emerg. Infect. Dis. 9:1151-1154. http://dx.doi.org/10.3201 /eid0909.030280.
9. Schwan TG, Raffel SJ, Schrumpf ME, Porcella SF. 2007. Diversity and distribution of Borrelia hermsii. Emerg. Infect. Dis. 13:436-442. http://dx .doi.org/10.3201/eid1303.060958.
10. Schwan TG, Raffel SJ, Schrumpf ME, Webster LS, Marques AR, Spano R, Rood M, Burns J, Hu R. 2009. Tick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, U.S.A. Emerg. Infect. Dis. 15: 1026-1031. http://dx.doi.org/10.3201/eid1507.090223.
11. Felsenfeld O. 1971. Borrelia. Strains, vectors, human and animal borreliosis. Warren H. Green, Inc., St. Louis, MO.
12. Cadavid D, Barbour AG. 1998. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology and treatment of infections in humans and experimental animals. Clin. Infect. Dis. 26:151-164. http://dx.doi.org/10.1086/516276.
13. McDowell JV, Miller DP, Mallory KL, Marconi RT. 2012. Treponema denticola: FhbB, dentilisin, complement evasion and the paradox of factor H cleavage, p 43-62. In Embers ME (ed), The pathogenic spirochetes: strategies for evasion of host immunity and persistence. Springer Science Business Media, New York, NY.
14. Zipfel PF, Hallstrom T, Hammerschmidt S, Skerka C. 2008. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci. Vaccine 26(Suppl 8):I67-I74.
15. Ferreira VP, Pangburn MK, Cortes C. 2010. Complement control protein factor H: the good, the bad, and the inadequate. Mol. Immunol. 47:2187-2197. http://dx.doi.org/10.1016/j.molimm.2010.05.007.
16. Ruddy S, Austen KF. 1969. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3. J. Immunol. 102:533-543.
17. Ruddy S, Austen KF. 1971. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.J. Immunol. 107:742-750.
18. Hovis KM, McDowell JV, Griffin L, Marconi RT. 2004. Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J. Bacteriol. 186:2612-2618. http://dx.doi.org/10.1128/JB.186.9.2612-2618.2004.
19. Rossmann E, Kraiczy P, Herzberger P, Skerka C, Kirschfink M, Simon MM, Zipfel PF, Wallich R. 2007. Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factorHand plasminogen discloses a putative virulence factor of relapsing fever spirochetes. J. Immunol. 178:7292-7301. http://dx.doi.org/10.4049 /jimmunol.178.11.7292.
20. Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala IJT, Meri S. 2001. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276:8427- 8435. http://dx.doi.org/10.1074/jbc.M007994200.
21. Kraiczy P, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel PF, Wallich R. 2003. Immune evasion of Borrelia burgdorferi: mapping of a complement-inhibitor factor H-binding site of BbCRASP-3, a novel member of the Erp protein family. Eur. J. Immunol. 33:697-707. http://dx .doi.org/10.1002/eji.200323571.
22. Kraiczy P, Skerka C, Zipfel PF. 2001. Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect. Immun. 69:7800-7809. http://dx.doi.org/10.1128/IAI.69.12.7800 -7809.2001.
23. McDowell JV, Wolfgang J, Tran E, Metts MS, Hamilton D, Marconi RT. 2003. Comprehensive analysis of the factor H binding capabilities of Borrelia species associated with Lyme disease: delineation of two distinct classes of factor H binding proteins. Infect. Immun. 71:3597-3602. http: //dx.doi.org/10.1128/IAI.71.6.3597-3602.2003.
24. Hovis KM, Jones JP, Sadlon T, Raval G, Gordon DL, Marconi RT. 2006. Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1. Infect. Immun. 74:2007-2014. http://dx.doi.org/10.1128/IAI.74.4.2007 -2014.2006.
25. Hovis KM, Schriefer ME, Bahlani S, Marconi RT. 2006. Immunological and molecular analyses of the Borrelia hermsii factor H and factor H-like protein 1 binding protein, FhbA: demonstration of its utility as a diagnostic marker and epidemiological tool for tick-borne relapsing fever. Infect. Immun. 74:4519-4529. http://dx.doi.org/10.1128/IAI.00377-06.
26. Hovis KM, Freedman JC, Zhang H, Forbes JL, Marconi RT. 2008. Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host-pathogen interaction. Infect. Immun. 76: 2113-2122. http://dx.doi.org/10.1128/IAI.01266-07.
27. McDowell JV, Tran E, Hamilton D, Wolfgang J, Miller K, Marconi RT. 2003. Analysis of the ability of spirochete species associated with relapsing fever, avian borreliosis, and epizootic bovine abortion to bind factor H and cleave C3b. J. Clin. Microbiol. 41:3905-3910. http://dx.doi.org/10 .1128/JCM.41.8.3905-3910.2003.
28. Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V. 2001. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int. Immunopharmacol. 1:3393-3401. http://dx.doi.org/10.1016/S1567 -5769(00)00041-2.
29. McDowell JV, Huang B, Fenno JC, Marconi RT. 2009. Analysis of a unique interaction between the complement regulatory protein factor H and the periodontal pathogen Treponema denticola. Infect. Immun. 77: 1417-1425. http://dx.doi.org/10.1128/IAI.01544-08.
30. Meri T, Amdahl H, Lehtinen MJ, Hyvarinen S, McDowell JV, Bhattacharjee A, Meri S, Marconi R, Goldman A, Jokiranta TS. 2013. Microbes bind complement inhibitor factor H via a common site. PLoS Pathog. 9:e1003308. http://dx.doi.org/10.1371/journal.ppat.1003308.
31. Zipfel PF. 2009. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 126:1-7. http://dx.doi.org/10 .1016/j.imlet.2009.07.005.
32. Zipfel PF, Skerka C, Hellwage J, Jokiranta ST, Meri S, Brade V, Kraiczy P, Noris M, Remuzzi G. 2002. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30:971-978.
33. Fine LM, Earnhart CG, Marconi RT. 2011. Genetic transformation of the relapsing fever spirochete Borrelia hermsii: stable integration and expression of green fluorescent protein from linear plasmid 200 (lp200). J. Bacteriol. 193:3241-3245. http://dx.doi.org/10.1128/JB.05037-11.
34. Lin T, Oliver JH, Jr, Gao L, Kollars TM, Jr, Clark KL. 2001. Genetic heterogeneity of Borrelia burgdorferi sensu lato in the southern United States based on restriction fragment length polymorphism and sequence analysis. J. Clin. Microbiol. 39:2500-2507. http://dx.doi.org/10.1128 /JCM.39.7.2500-2507.2001.
35. Marconi RT, Liveris D, Schwartz I. 1995. Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp.nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates. J. Clin. Microbiol. 33:2427-2434.
36. Carlyon JA, Marconi RT. 1998. Cloning and molecular characterization of a multicopy, linear plasmid-carried, repeat motif-containing gene from Borrelia turicatae, a causative agent of relapsing fever. J. Bacteriol. 180: 4974-4981.
37. Earnhart CG, Marconi RT. 2007. An octavalent Lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences. Hum. Vaccin. 3:281-289.
38. Labandeira-Rey M, Skare JT. 2001. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with the loss of either linear plasmid 25 or 28-1. Infect. Immun. 69:446-455. http://dx.doi.org/10.1128/IAI.69.1 .446-455.2001.
39. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. 1997. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89:1111- 1119. http://dx.doi.org/10.1016/S0092-8674(00)80298-6.
40. Nordstrand A, Shamaei-Tousi A, Ny A, Bergstrom S. 2001. Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogendeficient mice. Infect. Immun. 69:5832-5839. http://dx.doi.org/10.1128 /IAI.69.9.5832-5839.2001.
41. Guyard C, Battisti JM, Raffel SJ, Schrumpf ME, Whitney AR, Krum JG, Porcella SF, Rosa PA, DeLeo FR, Schwan TG. 2006. Relapsing fever spirochaetes produce a serine protease that provides resistance to oxidative stress and killing by neutrophils. Mol. Microbiol. 60:710-722. http: //dx.doi.org/10.1111/j.1365-2958.2006.05122.x.
42. Grosskinsky S, Schott M, Brenner C, Cutler SJ, Simon MM, Wallich R. 2010. Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl. Trop. Dis. 4:e698. http://dx.doi.org/10.1371 /journal.pntd.0000698.
43. Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS. 2006. Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect. Immun. 74:4157-4163. http://dx.doi.org/10.1128/IAI.00007-06.
44. Davis AE, III, Mejia P, Lu F. 2008. Biological activities of C1 inhibitor. Mol. Immunol. 45:4057-4063. http://dx.doi.org/10.1016/j.molimm.2008 .06.028.
45. Coleman JL, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL. 1995. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect. Immun. 63:2478-2484.
46. Barthel D, Schindler S, Zipfel PF. 2012. Plasminogen is a complement inhibitor. J. Biol. Chem. 287:18831-18842. http://dx.doi.org/10.1074/jbc .M111.323287.
47. McDowell JV, Hovis KM, Zhang H, Tran E, Lankford J, Marconi RT. 2006. Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals. Infect. Immun. 74:3030-3034. http://dx.doi .org/10.1128/IAI.74.5.3030-3034.2006.